The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Share

Personal info

View

Links

Table of contents

Affiliations

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Daniel J. DeAngelo

Department of Medical Oncology

Dana-Farber Cancer Institute

Boston

MA 02115

USA

[email]@partners.org

Name/email consistency: high

[Claim this account]

Affiliations

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. 2007 - 2010
Dana-Farber Cancer Institute, 44 Binney Street, D1B30, Boston, USA. 2005 - 2006

References

Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukemia: translating preclinical findings to clinical practice. DeAngelo, D.J., Attar, E.C. Leuk. Lymphoma (2010) [Pubmed]
Nelarabine for the treatment of patients with relapsed or refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. DeAngelo, D.J. Hematol. Oncol. Clin. North Am. (2009) [Pubmed]
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. DeAngelo, D.J., Yu, D., Johnson, J.L., Coutre, S.E., Stone, R.M., Stopeck, A.T., Gockerman, J.P., Mitchell, B.S., Appelbaum, F.R., Larson, R.A. Blood (2007) [Pubmed]
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. DeAngelo, D.J., Stone, R.M., Heaney, M.L., Nimer, S.D., Paquette, R.L., Klisovic, R.B., Caligiuri, M.A., Cooper, M.R., Lecerf, J.M., Karol, M.D., Sheng, S., Holford, N., Curtin, P.T., Druker, B.J., Heinrich, M.C. Blood (2006) [Pubmed]
The treatment of adolescents and young adults with acute lymphoblastic leukemia. DeAngelo, D.J. Hematology. Am. Soc. Hematol. Educ. Program (2005) [Pubmed]

WikiGenes - Universities